AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34089046 — intervention group
Group type: EXPERIMENTAL
Intervention: Earned Income Tax Credit (4-fold increase)
Number of subjects: 5968
Study 34089046 — intervention group
Group type: COMPARATOR
Intervention: Current federal Earned Income Tax Credit
Number of subjects: 5968
Study 33278614 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular hemiarthroplasty implant
Number of subjects: 958
Study 33278614 — intervention group
Group type: COMPARATOR
Intervention: Traditional monoblock implant
Number of subjects: 958
Study 33278614 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (EuroQol EQ5D)
Number of subjects: 958
Study 33278614 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of stay
Number of subjects: 958
Study 33137516 — intervention group
Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 15
Study 35935320 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofol anesthesia
Number of subjects: 96
Study 35935320 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 96
Study 35139910 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-mediated pelvic floor muscle training (PFMT) plus neuromuscular electrical stimulation (NMES)
Number of subjects: 274
Study 35139910 — intervention group
Group type: COMPARATOR
Intervention: Conventional pelvic floor muscle training (PFMT)
Number of subjects: 274
Study 35139910 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-mediated PFMT plus NMES
Number of subjects: 274
Study 35139910 — intervention group
Group type: COMPARATOR
Intervention: Conventional PFMT
Number of subjects: 274
Study 33009228 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC‐063 (100 mg/d)
Number of subjects: 3
Study 33009228 — intervention group
Group type: COMPARATOR
Intervention: Immediate‐release methylphenidate (20 mg, 3 times daily)
Number of subjects: 3
Study 33009228 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC‐063 sprinkled on food
Number of subjects: 3
Study 33009228 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC‐063 under fasted conditions
Number of subjects: 3
Study 33009228 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC‐063 under high-fat, high-calorie meal conditions
Number of subjects: 3
Study 35331230 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga with high dose vitamin D (4000 IU)
Number of subjects: 30
Study 35331230 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga with low dose vitamin D (2000 IU)
Number of subjects: 30
Study 35331230 — intervention group
Group type: COMPARATOR
Intervention: High dose vitamin D (4000 IU)
Number of subjects: 30
Study 33222470 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 0.4 µg/kg
Number of subjects: 71
Study 33222470 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 4 µg/kg
Number of subjects: 71
Study 34628979 — intervention group
Group type: EXPERIMENTAL
Intervention: Local vibration
Number of subjects: 100
Study 34628979 — intervention group
Group type: EXPERIMENTAL
Intervention: ShotBlocker
Number of subjects: 100
Study 34628979 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 32530869 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology applied for 30 minutes before the procedures
Number of subjects: 56
Study 32530869 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 56
Study 32530869 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 56
Study 33021585 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery (control)
Number of subjects: 14
Study 33021585 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (immersion in water 15° C for 10 minutes)
Number of subjects: 14
Study 33021585 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins C (1 g) and E (800 UI) supplementation 40 minutes before exercise
Number of subjects: 14
Study 33021585 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of vitamins (C and E) with cryotherapy
Number of subjects: 14
Study 34889772 — intervention group
Group type: EXPERIMENTAL
Intervention: My Stress Control (MSC) web-based program
Number of subjects: 92
Study 34889772 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 92
Study 32006455 — intervention group
Group type: EXPERIMENTAL
Intervention: Far infrared emitting bioceramics wraps
Number of subjects: 35
Study 32006455 — intervention group
Group type: COMPARATOR
Intervention: Placebo wraps
Number of subjects: 35
Study 34100742 — intervention group
Group type: EXPERIMENTAL
Intervention: Language intervention protocol combined with auditory verbal therapy (AVT)
Number of subjects: 60
Study 34100742 — intervention group
Group type: COMPARATOR
Intervention: Auditory verbal therapy (AVT)
Number of subjects: 60
Study 35779532 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive home treatment
Number of subjects: 246
Study 35779532 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 246
Study 33448539 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbol Digit Modalities Test (SDMT)
Number of subjects: 889
Study 33448539 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Test (PASAT)
Number of subjects: 889
Study 34596759 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP)
Number of subjects: 17
Study 34596759 — intervention group
Group type: COMPARATOR
Intervention: SHAM treatment
Number of subjects: 17
Study 33857800 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose group (n = 10) performed 4320 steps
Number of subjects: 20
Study 33857800 — intervention group
Group type: COMPARATOR
Intervention: Low dose group (n = 10) performed 144 steps
Number of subjects: 20
Study 35554747 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride (10mg)
Number of subjects: 6
Study 35554747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 32792771 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injection of triamcinolone acetonide (10 mg/mL)
Number of subjects: 40
Study 32792771 — intervention group
Group type: COMPARATOR
Intervention: Intralesional autologous platelet-rich plasma (PRP) injection
Number of subjects: 40
Study 36176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Padsevonil 50 mg
Number of subjects: 641
Study 36176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Padsevonil 100 mg
Number of subjects: 641
Study 36176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Padsevonil 200 mg
Number of subjects: 641
Study 36176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Padsevonil 400 mg
Number of subjects: 641
Study 36176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Padsevonil 100 mg (EP0092)
Number of subjects: 641
Study 36176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Padsevonil 200 mg (EP0092)
Number of subjects: 641
Study 36176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Padsevonil 400 mg (EP0092)
Number of subjects: 641
Study 36176044 — intervention group
Group type: COMPARATOR
Intervention: Placebo (EP0091)
Number of subjects: 641
Study 36176044 — intervention group
Group type: COMPARATOR
Intervention: Placebo (EP0092)
Number of subjects: 641
Study 33477112 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 18
Study 33477112 — intervention group
Group type: EXPERIMENTAL
Intervention: Elliptical Trainer
Number of subjects: 18
Study 33477112 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepper
Number of subjects: 18
Study 33477112 — intervention group
Group type: COMPARATOR
Intervention: All modalities (Treadmill, Elliptical Trainer, Stepper)
Number of subjects: 18
Study 32791665 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus 2 mg orally once daily for 16 weeks
Number of subjects: 20
Study 32791665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32791665 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 20
Study 35891255 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dose (DD) of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 130
Study 35891255 — intervention group
Group type: COMPARATOR
Intervention: Normal dose (ND) of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 130
Study 35891255 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dose (DD)
Number of subjects: 130
Study 35891255 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 130
Study 33487189 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC) intervention (n = 43)
Number of subjects: 122
Study 33487189 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (n = 51)
Number of subjects: 122
Study 33487189 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk parents (n = 79)
Number of subjects: 122
Study 33487189 — intervention group
Group type: EXPERIMENTAL
Intervention: CPS-referred parents who received ABC intervention
Number of subjects: 122
Study 33487189 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure base script knowledge
Number of subjects: 122
Study 33487189 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC intervention
Number of subjects: 122
Study 33027799 — intervention group
Group type: EXPERIMENTAL
Intervention: High tertile of net ultrafiltration (NUF) rate (>1.75 mL/kg/h)
Number of subjects: 941
Study 33027799 — intervention group
Group type: COMPARATOR
Intervention: Middle tertile of net ultrafiltration (NUF) rate (1.01-1.75 mL/kg/h)
Number of subjects: 941
Study 33027799 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tertile of net ultrafiltration (NUF) rate (<1.01 mL/kg/h)
Number of subjects: 941
Study 33027799 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline cardiovascular SOFA score
Number of subjects: 941
Study 32623361 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus bracing at maximum tension
Number of subjects: 32
Study 32623361 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus bracing (all tension levels)
Number of subjects: 32
Study 32623361 — intervention group
Group type: COMPARATOR
Intervention: No bracing (control condition)
Number of subjects: 32
Study 35448970 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based vision therapy
Number of subjects: 63
Study 35448970 — intervention group
Group type: COMPARATOR
Intervention: Office-based vergence/accommodative therapy
Number of subjects: 63
Study 34598980 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (10 sessions, 2 sessions per week)
Number of subjects: 113
Study 34598980 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (daily home-based for 5 weeks)
Number of subjects: 113
Study 32589230 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (2.5 mg orally twice daily)
Number of subjects: 400
Study 32589230 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin (40 mg subcutaneously daily)
Number of subjects: 400
Study 36356410 — intervention group
Group type: EXPERIMENTAL
Intervention: EVE esc (2.5 mg/day week 1; 5 mg/day week 2; 7.5 mg/day week 3; 10 mg/day weeks 4-24)
Number of subjects: 160
Study 36356410 — intervention group
Group type: COMPARATOR
Intervention: EVE 10mg (10 mg/day for 24 weeks plus exemestane)
Number of subjects: 160
Study 36356410 — intervention group
Group type: EXPERIMENTAL
Intervention: EVE esc
Number of subjects: 160
Study 36356410 — intervention group
Group type: COMPARATOR
Intervention: EVE 10mg
Number of subjects: 160
Study 34227158 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer child and parental exposure to electronic media
Number of subjects: 1667
Study 34227158 — intervention group
Group type: COMPARATOR
Intervention: Children at 18 months
Number of subjects: 1667
Study 34227158 — intervention group
Group type: COMPARATOR
Intervention: Children at 24 months
Number of subjects: 1667
Study 36175977 — intervention group
Group type: COMPARATOR
Intervention: Standard mental health care and vocational rehabilitation service (Service as Usual - SAU)
Number of subjects: 900
Study 34669900 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional teaching associated with simulated teaching
Number of subjects: 60
Study 34669900 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching
Number of subjects: 60
Study 32921984 — intervention group
Group type: EXPERIMENTAL
Intervention: QR code video education and traditional information leaflet (Group A)
Number of subjects: 154
Study 32921984 — intervention group
Group type: COMPARATOR
Intervention: Traditional information leaflet only (Group B)
Number of subjects: 154
Study 36035935 — intervention group
Group type: EXPERIMENTAL
Intervention: Original dose of neurohumoral blockades
Number of subjects: 50
Study 36035935 — intervention group
Group type: COMPARATOR
Intervention: Halved dose of neurohumoral blockades
Number of subjects: 50
Study 36035935 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of neurohumoral blockades
Number of subjects: 50
Study 33427861 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Navigation (FN)
Number of subjects: 249
Study 33427861 — intervention group
Group type: COMPARATOR
Intervention: Conventional Care Management (CCM)
Number of subjects: 249
Study 33427861 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Navigation (FN) among Hispanic families
Number of subjects: 249
Study 33427861 — intervention group
Group type: COMPARATOR
Intervention: Conventional Care Management (CCM) among Hispanic families
Number of subjects: 249
Study 33427861 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Navigation (FN) among non-Hispanic families
Number of subjects: 249
Study 33427861 — intervention group
Group type: COMPARATOR
Intervention: Conventional Care Management (CCM) among non-Hispanic families
Number of subjects: 249
Study 35209984 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent iron supplementation
Number of subjects: 147
Study 35209984 — intervention group
Group type: COMPARATOR
Intervention: Conventional iron supplementation
Number of subjects: 147
Study 36038890 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrated ventilation, sedation, and sweep gas flow
Number of subjects: 30
Study 36038890 — intervention group
Group type: EXPERIMENTAL
Intervention: VV-ECMO
Number of subjects: 30
Study 36038890 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP level associated with improved dynamic compliance
Number of subjects: 30
Study 36038890 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial neuromuscular blockade (pNMBA)
Number of subjects: 30
Study 34197132 — intervention group
Group type: EXPERIMENTAL
Intervention: pABI group
Number of subjects: 76
Study 34197132 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 76
Study 36042633 — intervention group
Group type: EXPERIMENTAL
Intervention: Phellinus linteus extract (1000 mg per day for 8 weeks)
Number of subjects: 98
Study 36042633 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1000 mg dextrin per day for 8 weeks)
Number of subjects: 98
Study 34023318 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized-dose corticosteroid therapy for 5 days
Number of subjects: 248
Study 34023318 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose corticosteroid therapy (40 mg of prednisolone) for 5 days
Number of subjects: 248
Study 34023318 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized-dose corticosteroid therapy
Number of subjects: 248
Study 34023318 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose corticosteroid therapy
Number of subjects: 248
Study 34023318 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized-dose corticosteroid therapy (40 mg or less)
Number of subjects: 248
Study 34023318 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized-dose corticosteroid therapy (more than 40 mg)
Number of subjects: 248
Study 33032560 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable skin suture with closure of the subcutaneous fascia (Group 4)
Number of subjects: 849
Study 33032560 — intervention group
Group type: COMPARATOR
Intervention: Non-absorbable skin suture with closure of the subcutaneous fascia (Group 3)
Number of subjects: 849
Study 33032560 — intervention group
Group type: COMPARATOR
Intervention: Absorbable skin suture without closure of the subcutaneous fascia (Group 2)
Number of subjects: 849
Study 33032560 — intervention group
Group type: COMPARATOR
Intervention: Non-absorbable skin suture without closure of the subcutaneous fascia (Group 1)
Number of subjects: 849
Study 34741631 — intervention group
Group type: EXPERIMENTAL
Intervention: IMAGE1S-assisted TURBT
Number of subjects: 689
Study 34741631 — intervention group
Group type: COMPARATOR
Intervention: WL-assisted TURBT
Number of subjects: 689
Study 34238446 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive prevention program (IPP)
Number of subjects: 0
Study 34238446 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 34238446 — intervention group
Group type: EXPERIMENTAL
Intervention: Short reinterventions (“Prevention Boosts”)
Number of subjects: 0
Study 36066508 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional cash transfer
Number of subjects: 453
Study 36066508 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconditional cash transfer
Number of subjects: 453
Study 36066508 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 453
Study 33103789 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-transfusion furosemide
Number of subjects: 1356
Study 33103789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1356
Study 35574948 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled reperfusion with delayed stenting (PCRDS)
Number of subjects: 20
Study 35574948 — intervention group
Group type: COMPARATOR
Intervention: Standard primary percutaneous coronary intervention with immediate stenting (IS)
Number of subjects: 20
Study 34176014 — intervention group
Group type: COMPARATOR
Intervention: Dexa‐BEAM (dexamethasone, carmustine, etoposide, cytarabine, melphalan; N = 37)
Number of subjects: 73
Study 34176014 — intervention group
Group type: EXPERIMENTAL
Intervention: MIFAP (mitoxantrone, fludarabine, cytarabine, cisplatin; N = 36)
Number of subjects: 73
Study 34176014 — intervention group
Group type: EXPERIMENTAL
Intervention: MIFAP
Number of subjects: 73
Study 34176014 — intervention group
Group type: COMPARATOR
Intervention: Dexa‐BEAM
Number of subjects: 73
Study 616886766 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Sanxiang Xiaopi decoction (80 mL through a stomach tube for 14 days)
Number of subjects: 80
Study 616886766 — intervention group
Group type: COMPARATOR
Intervention: Control group (enhanced anti-infection and nutrition support without modified Sanxiang Xiaopi decoction)
Number of subjects: 80
Study 616886766 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Sanxiang Xiaopi decoction
Number of subjects: 80
Study 33917503 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Lactoplantibacillus plantarum strains CECT7527, CECT7528, and CECT7529 plus 10 mg of monacolin K
Number of subjects: 39
Study 33917503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 35334144 — intervention group
Group type: EXPERIMENTAL
Intervention: Video condition featuring a personal/affective narrative
Number of subjects: 977
Study 35334144 — intervention group
Group type: EXPERIMENTAL
Intervention: Essay conditions prompting reflection
Number of subjects: 977
Study 35334144 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental conditions
Number of subjects: 977
Study 35334144 — intervention group
Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 977
Study 34831986 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-stand training combined with real-time visual feedback (RVF-STS group)
Number of subjects: 30
Study 34831986 — intervention group
Group type: COMPARATOR
Intervention: Classic sit-to-stand training (C-STS group)
Number of subjects: 30
Study 32163723 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean absolute glucose (MAG)
Number of subjects: 0
Study 32163723 — intervention group
Group type: EXPERIMENTAL
Intervention: Low blood glucose index
Number of subjects: 0
Study 32163723 — intervention group
Group type: EXPERIMENTAL
Intervention: Index of glycemic control
Number of subjects: 0
Study 32163723 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage time in glucose target 70-180 mg/dL
Number of subjects: 0
Study 35487505 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum LMT1-48 (2×10^10 CFU)
Number of subjects: 100
Study 35487505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33632215 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital information tool with VR-technology and standard care (oral and written information)
Number of subjects: 160
Study 33632215 — intervention group
Group type: COMPARATOR
Intervention: Standard care and information (oral and written)
Number of subjects: 160
Study 35699834 — intervention group
Group type: EXPERIMENTAL
Intervention: sunitinib
Number of subjects: 52
Study 35699834 — intervention group
Group type: EXPERIMENTAL
Intervention: bevacizumab
Number of subjects: 52
Study 34636527 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise training program (30-45 minutes, 50-70% heart rate reserve) on the AlterG treadmill for 12 weeks
Number of subjects: 62
Study 34636527 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 34670021 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for incidental findings (IFs)
Number of subjects: 1838
Study 34670021 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for blood-borne virus infection
Number of subjects: 1838
Study 34670021 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for elevated alanine transaminase (ALT)
Number of subjects: 1838
Study 34670021 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of social habits
Number of subjects: 1838
Study 34293164 — intervention group
Group type: EXPERIMENTAL
Intervention: Large change intervention
Number of subjects: 599
Study 34293164 — intervention group
Group type: EXPERIMENTAL
Intervention: Small change intervention
Number of subjects: 599
Study 32641090 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-min blind
Number of subjects: 500
Study 32641090 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 min with guidance
Number of subjects: 500